Question 1

How does Harshingar work to reduce fever?

Accepted Answer

Harshingar (Nyctanthes arbor-tristis) contains active compounds including iridoid glycosides, nyctanthoside, and beta-sitosterol that demonstrate antipyretic properties. These compounds appear to work by inhibiting prostaglandin synthesis and modulating inflammatory pathways in the body. The leaves also contain tannins and mannitol which contribute to its therapeutic effects. Research suggests these bioactive constituents help regulate body temperature through anti-inflammatory mechanisms, though evidence remains preliminary (Level C). Traditional Ayurvedic use supports its effectiveness for managing intermittent fevers.

Question 2

Can I take Harshingar if I am on blood thinners?

Accepted Answer

No, Harshingar should not be taken if you are on blood-thinning medications. This herb may interact with anticoagulants such as warfarin, aspirin, or clopidogrel, potentially increasing the risk of bleeding. The presence of active compounds like iridoid glycosides may affect blood clotting mechanisms. If you are taking any blood thinners, consult your healthcare provider before using Harshingar or any herbal supplements. This interaction is significant enough that Harshingar is contraindicated for individuals on anticoagulant therapy.

Question 3

What is the recommended dosage of Harshingar leaf?

Accepted Answer

The typical adult dosage of Harshingar is 2-4 grams of dried leaf prepared as a tea, taken once or twice daily. Alternatively, a standardized extract of approximately 500mg may be used. Traditional Ayurvedic preparations often use fresh or dried leaves steeped in hot water for 10-15 minutes. Dosage may vary based on the specific condition being treated and individual factors. Always follow product label instructions or consult a qualified herbalist for personalized dosing recommendations, as higher doses may increase the risk of gastrointestinal side effects.

Question 4

Is Harshingar safe to use during pregnancy?

Accepted Answer

No, Harshingar is not considered safe during pregnancy. This herb is contraindicated for pregnant women due to insufficient safety data and potential uterine-stimulating effects that could pose risks to the developing fetus. Traditional use and available evidence (Level C) do not support its use during pregnancy. Women who are pregnant or planning to become pregnant should avoid Harshingar in all forms, including teas and extracts. Breastfeeding women should also exercise caution and seek medical advice before use.

Question 5

What is Harshingar used for in Ayurvedic medicine?

Accepted Answer

Harshingar, also known as Night Jasmine or Parijat, has been used in Ayurvedic and folk medicine primarily for treating intermittent fevers, including malaria-like symptoms. The leaves and flowers are traditionally employed for managing rheumatism, joint pain, and inflammatory conditions. Additional traditional uses include treating cough, asthma, and digestive complaints. The herb is considered sacred in Hindu culture and is often used in religious ceremonies. Current evidence supporting these uses is rated at Level C, indicating limited clinical evidence but established traditional use.

Question 6

What are the side effects of Harshingar?

Accepted Answer

Harshingar is generally well-tolerated at recommended doses, but some individuals may experience side effects. The most commonly reported adverse effects include gastrointestinal upset such as nausea, stomach discomfort, or loose stools. Mild allergic reactions, including skin rash or itching, may occur in sensitive individuals. These side effects are typically dose-dependent and may resolve by reducing the amount taken. If you experience severe symptoms such as difficulty breathing, swelling, or persistent digestive issues, discontinue use and seek medical attention.

Harshingar

Sources & Citations

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources